Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Nasopharyngeal Carcinoma 20Carcinoma, Non-Small-Cell Lung 18Esophageal Squamous Cell Carcinoma 15Breast Neoplasms 14Triple Negative Breast Neoplasms 13Squamous Cell Carcinoma of Head and Neck 11Carcinoma, Hepatocellular 11Stomach Neoplasms 8Small Cell Lung Carcinoma 8Uterine Cervical Neoplasms 6Recurrence 6Head and Neck Neoplasms 6Colorectal Neoplasms 6Carcinoma, Transitional Cell 5Carcinoma, Renal Cell 5Urinary Bladder Neoplasms 4Sarcoma 4Rectal Neoplasms 4Neoplasm Metastasis 4Melanoma 4Laryngeal Neoplasms 4Hypopharyngeal Neoplasms 4Locally Advanced Rectal Cancer 3Liver Neoplasms 3Turcot syndrome 2Pathologic Complete Response 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Oropharyngeal Neoplasms 2Nasopharyngeal Neoplasms 2

Interventions

Cisplatin 32Radiotherapy, Intensity-Modulated 17Radiotherapy 17Carboplatin 14Radiation 11Magnetic Resonance Spectroscopy 10Cetuximab 8Specimen Handling 7Platinum 7Paclitaxel 71,2-diaminocyclohexaneplatinum II citrate 7Docetaxel 6Chemoradiotherapy 6Surgical Procedures, Operative 5pembrolizumab 4Nivolumab 4Celecoxib 4cemiplimab 3Taxes 3Surveys and Questionnaires 3Fluorouracil 3Drug Therapy 3toripalimab 2durvalumab 2aldesleukin 2X-Rays 2Standard of Care 2Restraint, Physical 2Observation 2Neck Dissection 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Oropharyngeal Neoplasms × toripalimab × Clear all
NCT07209189 2026-04-23

(NeoScorch HN)

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Recruiting
75 enrolled
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Papillomavirus Infections

NCT07290621 2026-02-06

Toripalimab in Combination With Standard Treatment for Human Papillomavirus (HPV) Positive Throat Cancer

University of Chicago

Phase 2 Recruiting
30 enrolled
Head & Neck

Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡